Rabbit Polyclonal B3GNT antibody. Suitable for IHC-P and reacts with Human samples. Immunogen corresponding to Recombinant Fragment Protein within Human B4GAT1 aa 150 to C-terminus.
pH: 7.4
Preservative: 0.03% Proclin 300
Constituents: PBS, 50% Glycerol (glycerin, glycerine)
IHC-P | |
---|---|
Human | Tested |
Mouse | Predicted |
Cow | Predicted |
Orangutan | Predicted |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 1/20.00000 - 1/200.00000 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse, Cow, Orangutan | Dilution info - | Notes - |
Beta-1,4-glucuronyltransferase involved in O-mannosylation of alpha-dystroglycan (DAG1) (PubMed:19587235, PubMed:23359570, PubMed:25279697, PubMed:25279699). Transfers a glucuronic acid (GlcA) residue onto a xylose (Xyl) acceptor to produce the glucuronyl-beta-1,4-xylose-beta disaccharide primer, which is further elongated by LARGE1, during synthesis of phosphorylated O-mannosyl glycan (PubMed:25279697, PubMed:25279699). Phosphorylated O-mannosyl glycan is a carbohydrate structure present in alpha-dystroglycan (DAG1), which is required for binding laminin G-like domain-containing extracellular proteins with high affinity (PubMed:25279697, PubMed:25279699). Required for axon guidance; via its function in O-mannosylation of alpha-dystroglycan (DAG1) (By similarity).
B3GNT1, B3GNT6, B4GAT1, Poly-N-acetyllactosamine extension enzyme, iGnT
Rabbit Polyclonal B3GNT antibody. Suitable for IHC-P and reacts with Human samples. Immunogen corresponding to Recombinant Fragment Protein within Human B4GAT1 aa 150 to C-terminus.
pH: 7.4
Preservative: 0.03% Proclin 300
Constituents: PBS, 50% Glycerol (glycerin, glycerine)
Purity greater than 95%.
Abcam is leading the way to address reproducibility in scientific research with our highly validated recombinant monoclonal and recombinant multiclonal antibodies. Search & select one of Abcam's thousands of recombinant alternatives to eliminate batch-variability and unnecessary animal use.
If you do not find a host species to meet your needs, our catalogue and custom Chimeric range provides scientists the specificity of Abcam's RabMAbs in the species backbone of your choice. Remember to also review our range of edited cell lines, proteins and biochemicals relevant to your target that may help you further your research goals.
Abcam antibodies are extensively validated in a wide range of species and applications, so please check the reagent specifications meet your scientific needs before purchasing. If you have any questions or bespoke requirements, simply visit the Contact Us page to send us an inquiry or contact our Support Team ahead of purchase.
B3GNT also known as Beta-13-N-acetylglucosaminyltransferase is an enzyme that facilitates the transfer of N-acetylglucosamine from UDP-GlcNAc to various substrates. It often involves the synthesis of poly-N-acetyllactosamine chains. B3GNT family proteins weigh around 45 kDa although variations might exist. This enzyme mostly expresses in tissues such as the liver spleen and lungs. During mechanical processes B3GNT operates in the Golgi apparatus and actively participates in glycosylation processes.
B3GNT enzymes play an important role in creating and modifying glycan structures on glycoproteins and glycolipids. Complex assemblies form with other glycosyltransferases for the efficient construction and regulation of glycan chains. These glycan structures are important for cellular processes like cell adhesion migration and signal transduction. By shaping these vital cellular events B3GNT contributes to fundamental biological functions and cell interactions.
B3GNT performs essential functions in the glycosphingolipid biosynthesis and Notch signaling pathways. These pathways govern cell fate determination morphogenesis and differentiation. B3GNT interacts with various proteins including fucosyltransferases and sialyltransferases during the synthesis of complex glycan structures. The Notch signaling pathway also involves proteins such as Notch receptors and ligands where B3GNT influences receptor-ligand interactions through glycosylation modifications impacting the signaling outcomes.
B3GNT dysfunction correlates with conditions like cancer and congenital disorders of glycosylation. Changes in glycan structures due to altered B3GNT activity often link with tumorigenesis and cancer metastasis. B3GNT's relationship with proteins like E-cadherin in cancer can affect E-cadherin-mediated cell adhesion promoting invasive behavior. In congenital disorders of glycosylation irregularities in glycan structures reflect defects in early developmental processes leading to multisystemic symptoms. These conditions emphasize the importance of B3GNT in maintaining normal cellular functions.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
Paraffin-embedded human kidney tissue stained for B3GNT using ab238818 at 1/100 dilution in immunohistochemical analysis.
Paraffin-embedded human brain tissue stained for B3GNT using ab238818 at 1/100 dilution in immunohistochemical analysis.
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com